l-carnitine wada prohibited list The 2025 of Substances: What You Need to Know The WADA Prohibited List for

Marotta A, Sarno E, Del Casale A, et al

Critically, however, direct evidence evaluating the efficacy of L-carnitine specifically for treating neonatal cerebral ischemic injury is currently lacking

There was no significant differences between the effects of the daily oral maintenance dosages of 2 g and 6 g on heart failure (RR = 0.53, 95% CI [0.25-1.13], P = 0.10), unstable angina (RR = 0.90, 95% CI [0.51-1.58], P = 0.71), or myocardial reinfarction (RR = 0.74, 95% CI [0.30-1.80], P = 0.50)

Pode contribuir para maior disposio e rendimento fsico

Y.et al (2020)

Long-term l-carnitine treatment of chronic anaemia of patients with end-stage renal failure